T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Fortinet
FTNT
|
+$2.09B |
| 2 |
Rockwell Automation
ROK
|
+$1.46B |
| 3 |
Autodesk
ADSK
|
+$1.19B |
| 4 |
Citigroup
C
|
+$1.11B |
| 5 |
ConocoPhillips
COP
|
+$1.08B |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$3.23B |
| 2 |
GE Aerospace
GE
|
+$2.12B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.46B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.17B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| 1 | Technology | 32.25% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.37% |
| 5 | Communication Services | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
MGM Resorts International
MGM
$9.53B
| $26.6M | ﹤0.01% |
563,444
+5,968
| +1% | +$282K |
|
902
Prestige Consumer Healthcare
PBH
$3.17B
| $26.6M | ﹤0.01% |
366,159
-39,130
| -10% | -$2.84M |
|
903
Clorox
CLX
$15.1B
| $26.5M | ﹤0.01% |
172,767
-44,489
| -20% | -$6.81M |
|
904
Zai Lab
ZLAB
$3.63B
| $26.4M | ﹤0.01% |
1,650,787
-1,053,668
| -39% | -$16.9M |
|
905
Warner Bros
WBD
$45.6B
| $26.1M | ﹤0.01% |
2,990,840
+23,543
| +0.8% | +$206K |
|
906
Evertec
EVTC
$2.15B
| $26.1M | ﹤0.01% |
654,122
-734
| -0.1% | -$29.3K |
|
907
AMN Healthcare
AMN
$704M
| $26M | ﹤0.01% |
416,229
-96,158
| -19% | -$6.01M |
|
908
Principal Financial Group
PFG
$18.3B
| $26M | ﹤0.01% |
301,321
-3,129
| -1% | -$270K |
|
909
Jacobs Solutions
J
$17.7B
| $26M | ﹤0.01% |
204,148
+435
| +0.2% | +$55.3K |
|
910
Hilton Grand Vacations
HGV
$4.02B
| $25.9M | ﹤0.01% |
549,043
+755
| +0.1% | +$35.6K |
|
|
CHX
911
DELISTED
ChampionX
CHX
| $25.9M | ﹤0.01% |
720,438
-1,896,181
| -72% | -$68.1M |
|
|
PWSC
912
DELISTED
PowerSchool Holdings, Inc.
PWSC
| $25.9M | ﹤0.01% |
1,214,232
+62,870
| +5% | +$1.34M |
|
913
Masco
MAS
$15.5B
| $25.8M | ﹤0.01% |
327,086
-2,117
| -0.6% | -$167K |
|
914
Amphastar Pharmaceuticals
AMPH
$1.31B
| $25.7M | ﹤0.01% |
584,544
-2,413
| -0.4% | -$106K |
|
915
iRhythm Technologies
IRTC
$5.77B
| $25.6M | ﹤0.01% |
220,621
-171,833
| -44% | -$19.9M |
|
916
Ormat Technologies
ORA
$5.52B
| $25.5M | ﹤0.01% |
385,912
-16,399
| -4% | -$1.09M |
|
917
Hexcel
HXL
$4.97B
| $25.1M | ﹤0.01% |
344,342
+207,434
| +152% | +$15.1M |
|
918
Labcorp
LH
$23.2B
| $25M | ﹤0.01% |
114,488
+2,934
| +3% | +$641K |
|
919
ASGN Inc
ASGN
$2.28B
| $25M | ﹤0.01% |
238,413
+21,625
| +10% | +$2.27M |
|
920
BridgeBio Pharma
BBIO
$9.92B
| $24.9M | ﹤0.01% |
803,956
+145,594
| +22% | +$4.5M |
|
921
Invesco
IVZ
$9.98B
| $24.8M | ﹤0.01% |
1,497,405
+58,332
| +4% | +$968K |
|
922
Kulicke & Soffa
KLIC
$2.02B
| $24.8M | ﹤0.01% |
492,350
-283,355
| -37% | -$14.3M |
|
923
Valvoline
VVV
$5.11B
| $24.7M | ﹤0.01% |
554,316
+34,467
| +7% | +$1.54M |
|
924
Rapid7
RPD
$1.29B
| $24.7M | ﹤0.01% |
503,468
+18,907
| +4% | +$927K |
|
925
Ally Financial
ALLY
$12.9B
| $24.7M | ﹤0.01% |
608,179
+432,350
| +246% | +$17.5M |
|